IGAMBIT Announces Sale of Gotham Subsidiary

SMITHTOWN, NY--(Marketwired - Nov 11, 2015) - iGambit Inc. (OTCQB: IGMB), a diversified holding company, announced that on November 5, 2015, through its wholly owned subsidiary Gotham Innovation Lab, Inc. ("Gotham") it sold certain assets of the Gotham business to VHT, Inc ("VHT").

A copy of the Form 8-K report may be accessed at www.sec.gov.

John Salerno, Chairman and CEO of iGambit, said, "Gotham has been a useful and rewarding subsidiary and we wish VHT much success with this new acquisition. We will use the proceeds of the sale to further our business efforts with our recently acquired email archiving management solutions business, ArcMail."

About iGambit Inc: iGambit (OTCQB: IGMB) is a fully reporting publicly-held company. We are a diversified holding company pursuing and evaluating a number of strategic objectives. These objectives include, among others, the potential acquisition of small- to medium-size businesses. We believe that the background of our management and of our Board of Directors in the technology markets is a valuable resource that makes us a desirable business partner to the companies that we are seeking to acquire. When we acquire a company, we work to assume an active role in the development and growth of the company, providing both strategic guidance and operational support. Once a company joins our partner company network, our collective expertise is leveraged to help position that company to produce high-margin, recurring and predictable earnings and generate long-term value for our stockholders. For more information, please visit www.igambit.com. Information on our website does not comprise a part of this press release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this document and elsewhere by iGambit are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward- looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. and U.S. government policies and regulations, including, but not limited to those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in iGambit Inc.'s filings with the Securities and Exchange Commission.